Shigeki Motomura

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma.

The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma.

Journal: Leukemia & lymphoma

Published: June 21, 2016

Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma.

Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma.

Journal: International journal of laboratory hematology

Published: June 17, 2016

Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy.

Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy.

Journal: Leukemia research

Published: June 20, 2015

Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.

Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.

Journal: Annals of hematology

Published: June 11, 2015

Dissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Dissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Journal: Leukemia & lymphoma

Published: February 04, 2015

R-CHOP therapy alone for limited-stage follicular lymphoma.

R-CHOP therapy alone for limited-stage follicular lymphoma.

Journal: Leukemia research

Published: November 30, 2014

Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy.

Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy.

Journal: Leukemia research

Published: August 29, 2014

Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy.

Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy.

Journal: Medical oncology (Northwood, London, England)

Published: June 29, 2014

Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.

Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.

Journal: Leukemia & lymphoma

Published: June 11, 2014

Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study.

Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study.

Journal: Leukemia & lymphoma

Published: February 18, 2014

Post-treatment PET-CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass.

Post-treatment PET-CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: January 24, 2014

Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.

Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.

Journal: European journal of haematology

Published: October 21, 2013

Showing 1-12 of 21

Last Updated: 09/26/2026